A1 Refereed original research article in a scientific journal

Advanced Prostate Cancer Treated with Intermittent or Continuous Androgen Deprivation in the Randomised FinnProstate Study VII – Quality of Life and Adverse Effects



Subtitle: Quality of Life and Adverse Effects

Authors: Salonen AJ, Taari K, Ala-Opas M, Viitanen J, Lundstedt S, Tammela TLJ, the FinnProstate Group (incl. Laato M Nurmi M)

Publisher: ELSEVIER SCIENCE BV

Publication year: 2013

Journal: European Urology

Journal name in source: EUROPEAN UROLOGY

Journal acronym: EUR UROL

Number in series: 1

Volume: 63

Issue: 1

First page : 111

Last page: 120

Number of pages: 10

ISSN: 0302-2838

DOI: https://doi.org/10.1016/j.eururo.2012.07.040(external)


Abstract
Conclusions: IAD showed benefits in the treatment of advanced PCa with respect to QoL. The prevalence of AEs was not significantly lower with IAD. Trial registration: ClinicalTrials.gov, NCT00293670. (C) 2012 European Association of Urology. Published by Elsevier B. V. All rights reserved.



Last updated on 2024-26-11 at 22:42